Thymosin Alpha 1 is a 28-amino acid peptide naturally produced by the thymus gland that acts as a potent immune modulator by promoting T-cell maturation and enhancing the activity of Natural Killer cells. It is primarily used in clinical research settings to restore immune function and improve the host response to chronic viral infections, certain cancers, and immunosenescence. First isolated in 1977 from "Thymosin Fraction 5," it is recognized as a potent biological response modifier that plays a central role in the maturation and modulation of the immune system.

Tα1 is "pleiotropic," meaning it acts on multiple pathways to achieve immune homeostasis. It does not just "boost" the immune system; it modulates it by balancing pro-inflammatory and anti-inflammatory signals.